SCHEMBL20672744

SCHEMBL20672744

NC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 10/20 0.65
ROCK1 Q13464 8/20 0.65
MAP4K4 O95819 3/20 0.65
CLK2 P49760 3/20 0.65
DYRK1A Q13627 3/20 0.65
CLK4 Q9HAZ1 3/20 0.65
PRKD3 O94806 2/20 0.65
RPS6KB1 P23443 2/20 0.65
PRKG1 Q13976 2/20 0.65
PRKD2 Q9BZL6 2/20 0.65
SGK2 Q9HBY8 2/20 0.65
STK17A Q9UEE5 2/20 0.65
CDC7 O00311 1/20 0.60
PLK4 O00444 1/20 0.60
CHEK1 O14757 1/20 0.60
DCLK1 O15075 1/20 0.60
MAPK13 O15264 1/20 0.60
PDPK1 O15530 1/20 0.60
DAPK3 O43293 1/20 0.60
DYRK3 O43781 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23430169 0.88 ROCK2 (0.59) ROCK2ROCK1MAP4K4CLK2DYRK1A
SCHEMBL23430082 0.88 NPC1 (0.65) ROCK2ROCK1MAP4K4CLK2DYRK1A
SCHEMBL23429984 0.88 ROCK2 (0.64) ROCK2ROCK1MAP4K4CLK2DYRK1A
SCHEMBL1457361 0.87 ROCK2 (0.63) ROCK2ROCK1MAP4K4CLK2DYRK1A
SCHEMBL23430076 0.85 NPC1 (0.67) ROCK2ROCK1MAP4K4CLK2DYRK1A
SCHEMBL20672732 0.85 MEN1 (0.62) ROCK2ROCK1MAP4K4CLK2DYRK1A
SCHEMBL20661267 0.84 ROCK2 (0.62) ROCK2ROCK1MAP4K4CLK2DYRK1A
SCHEMBL20661236 0.82 ROCK2 (0.60) ROCK2ROCK1MAP4K4CLK2DYRK1A
SCHEMBL20661228 0.81 ROCK2 (0.63) ROCK2ROCK1MAP4K4CLK2DYRK1A
SCHEMBL23429983 0.81 ROCK2 (0.64) ROCK2ROCK1MAP4K4CLK2DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163421-A1 INHIBITORS OF RHO ASSOCIATED COILED-COIL CONTAINING PROTEIN KINASE KADMON PHARMACEUTICALS, LLC 2021-06-03 US disclosed
WO-2019018853-A1 INHIBITORS OF RHO ASSOCIATED COILED-COIL CONTAINING PROTEIN KINASE KADMON CORPORATION, LLC (US) 2019-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210163421-A1 INHIBITORS OF RHO ASSOCIATED COILED-COIL CONTAINING PROTEIN KINASE ROCK1, ROCK2, RHOT2 ROCK2 2/4885ROCK1 1/4885MAP4K4 361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.